This study tested three psychosocial measures for their potential to serve as counseling goals for promoting ART to transgender women living with HIV (TWLH).
Methods:
Among 69 TWLH, 17.4% were not taking ART; these volunteers were compared to the remainder using multivariate regression analyses.
Results:
Only one psychosocial measure achieved significance: Personal Competence (Adjusted Odds Ratio = 0.80, 95% CI = 0.67–0.97, P = 0.02). Because this was a continuous measure, assessed on a 7-point scale, the protective adjusted odds ratio of 0.80 represents a 20% reduction in the odds of not taking ART for each unit of increase in this construct.
Conclusion:
Findings suggest a potential counseling goal for TWLH not taking ART.
Get full access to this article
View all access options for this article.
References
1.
Centers for Disease Control and Prevention. HIV in the United States: the stages of care. Available at: www.cdc.gov/nchhstp/newsroom/docs/2012/Stages-of-CareFactSheet-508.pdf Accessed February3, 2013.
2.
AlthoffKN, BuchaczK, HallHI, et al.U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med, 2012; 157:325–335.
3.
Evaluating the contribution of ancillary services in improving access to primary care in the United States under the Ryan White CARE Act. AIDS Care, 2002; 14(suppl 1):3–136.
4.
MugaveroMJ, AmicoKR, HornT, ThompsonMA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis, 2013; 57:1164–1171.
5.
GardnerEM, McLeesMP, SteinerJF, et al.The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis, 2011; 52:793–800.
6.
CorlessIB, HoytAJ, Tyer-ViolaL, et al.90-90-90 Plus: maintaining adherence to antiretroviral therapies. AIDS Patient Care STDS, 2017; 31:227–236.
7.
SweeneySM, VanablePA. The Association of HIV-related stigma to HIV medication adherence: a systematic review and synthesis of the literature. AIDS Behav, 2016; 20:29–50.
8.
BaralSD, PoteatT, StrömdahlS, et al.Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet, 2013; 13:214–222.
9.
HerbstJH, JacobsED, FinlaysonTJ, et al.Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav, 2008; 12:1–17.
10.
NuttbrockL, HwahngS, BocktingW, et al.Lifetime risk factors for HIV/sexually transmitted infections among male-to-female transgender persons. JAIDS, 2009; 52:417–421.
11.
SeveliusJM, CarricoA, JohnsonMO. Antiretroviral adherence among transgender women living with HIV. J Assoc Nurse AIDS Care, 2010; 21:256–264.
12.
SeveliusJM, SaberiP, JohnsonMO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care, 2014; 26:976–982.
13.
MachtingerEL, HabererJE, WilsonTC, WeissDS. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS Behav, 2012; 16:2160–2170.
14.
MizunoY, FrazierEL, HuangP, SkarbinskiJ. Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Health, 2015; 2:228–234.
15.
FraserL, De CuypereG. Psychotherapy with transgender people. In Principles of Transgender Medicine and Surgery. EtterR, MonstrayS, ColemanE (eds). New York, NY: Routledge, 2016, pp. 120–136.
16.
TorresCG, RenfrewM, KenstK, et al.Improving transgender health by building safe clinical environments that promote existing resilience: results from a qualitative analysis of providers. BMC Pediatr, 2015; 15:1.
17.
BocktingWO, MinerMH, RomineRES, et al.Stigma, mental health, and resilience in an online sample of the US transgender population. Am J Public Health, 2013; 103:943–951.
18.
CrosbyRA, SalazarLS, HillBJ. Gender affirmation and resiliency among Black transgender women with and without HIV infection. Transgender Health, 2016; 1:86–93.
19.
BlashillAJ, PerryN, SafrenSA. Mental health: a focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes. Curr HIV/AIDS Rep, 2011; 8:21–5.
20.
KraemerB, DelsignoreA, SchnyderU, HeppU. Body image and transsexualism. Psychopathology, 2008; 41:96–100.
21.
MoradiB. Addressing gender and cultural diversity in body image: objectification theory as a framework for integrating theories and grounding research. Sex Roles, 2010; 63:138–148.
22.
WagnildGM, YoungHM. Development and psychometric evaluation of the Resilience Scale. J Nurs Meas, 1993; 1:165–178.
23.
Clements-NolleK, MarxR, GuzmanR, KatzM. HIV prevalence, risk behaviors, health care use, mental health status of transgender persons: implications for public health intervention. Am J Public Health, 2001; 91:915–921.
24.
BrennanJ, KuhnsLM, JohnsonAK, BelzerM, et al.Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization. Am J Public Health, 2010; 102:1751–1757.
25.
ColemanE, BocktingW, BotzerM, et al.Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism, 2012; 13:165–232.
26.
National HIV/AIDS Strategy for the United States: Updated to 2020. Office of National AIDS Policy, 2015, pp. 1–65.
27.
PitasiMA, OrakaE, ClarkH, et al.HIV testing among transgender women and men—27 statwes and Guam, 2014–2015. Morb Mortal Wkly Rep, 2017; 66:883–887.
28.
RaifordJL, HallGJ, TaylorRD, et al.The role of structural barriers in sexual risk behavior, victimization and readiness to change HIV/STI-related risk behaviors among transgender women. AIDS Behav, 2016; 20:2012–2022.
